Abstract:T-cell immune responses modulated by T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) during Mycobacterium tuberculosis (Mtb) infection in humans remain poorly understood. Here, we found that active TB patients exhibited increases in numbers of Tim-3-expressing CD4(+) and CD8(+) T cells, which preferentially displayed polarized effector memory phenotypes. Consistent with effector phenotypes, Tim-3(+)CD4(+) and Tim-3(+)CD8(+) T-cell subsets showed greater effector functions for producing Th1/Th22 cytokines and CTL effector molecules than Tim-3(-) counterparts, and Tim-3-expressing T cells more apparently limited intracellular Mtb replication in macrophages. The increased effector functions for Tim-3-expressing T cells consisted with cellular activation signaling as Tim-3(+)CD4(+) and Tim-3(+)CD8(+) T-cell subsets expressed much higher levels of phosphorylated signaling molecules p38, stat3, stat5, and Erk1/2 than Tim-3-controls. Mechanistic experiments showed that siRNA silencing of Tim-3 or soluble Tim-3 treatment interfering with membrane Tim-3-ligand interaction reduced de novo production of IFN-gamma and TNF-alpha by Tim-3-expressing T cells. Furthermore, stimulation of Tim-3 signaling pathways by antibody cross-linking of membrane Tim-3 augmented effector function of IFN-gamma production by CD4(+) and CD8(+) T cells, suggesting that Tim-3 signaling helped to drive stronger effector functions in active TB patients. This study therefore uncovered a previously unknown mechanism for T-cell immune responses regulated by Tim-3, and findings may have implications for potential immune intervention in TB.

Tim-3 ligand galectin-9 reduces IL-17 level and accelerates Klebsiella pneumoniae infection

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

TIM-3 on myeloid cells promotes pulmonary inflammation through increased production of galectin-3

Interaction of TIM4 and TIM3 Induces T Helper 1 Cell Apoptosis

Activated Galectin-9/Tim3 Promotes Treg and Suppresses Th1 Effector Function in Chronic Lymphocytic Leukemia

Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells

T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses

Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis

Tim-3 Promotes <i>Listeria monocytogenes</i> Immune Evasion by Suppressing Major Histocompatibility Complex Class I

Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients.

The Relationship Between Tim-3 and the Ligand Galectin-9 and Virus Infection

Role of Tim-3 in pathogenesis of inflammatory diseases of the digestive system

Tim-3: An Activation Marker and Activation Limiter of Innate Immune Cells

Tim-3 Inhibits Macrophage Control of Listeria Monocytogenes by Inhibiting Nrf2

Tim-3-Expressing Cd4(+) And Cd8(+) T Cells In Human Tuberculosis (Tb) Exhibit Polarized Effector Memory Phenotypes And Stronger Anti-Tb Effector Functions

Tim-3 Blockade Decreases the Apoptosis of CD8+ T Cells and Reduces the Severity of Sepsis in Mice

T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response

Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells

Elevated Expression of Tim-3 on CD8 T Cells Correlates with Disease Severity of Pulmonary Tuberculosis.

Involvement of T Cell Ig Mucin-3 (Tim-3) in the Negative Regulation of Inflammatory Bowel Disease.